Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

Baricitinib is a promising treatment for alopecia areata.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

A comprehensive scoring system for alopecia areata severity is needed.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Baricitinib may effectively treat nail changes in alopecia areata.

Staphylococcus aureus affects immune responses and skin cells in atopic dermatitis, suggesting new treatment targets.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

AI can accurately measure hair loss severity in alopecia areata.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Vitamin D supplements should be used cautiously in sarcoidosis patients, with regular monitoring to avoid high calcium levels.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Baricitinib is not very effective for severe alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Oral zinc therapy is effective for treating acrodermatitis enteropathica.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disabilities.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

rwSALT accurately measures hair regrowth in alopecia areata using scalp photos.

Oral Apremilast effectively treats alopecia areata in most patients.

Photobiomodulation therapy effectively promotes hair regrowth and improves quality of life in alopecia areata without side effects.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.